Obesity trials in Spain
89 of 111 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
- Where
- A Coruña, Badalona, Barcelona, Córdoba, Denia, Las Palmas De Gran Canaria, L'hospitalet De Llobregat, Lleida, Madrid, Majadahonda, Málaga, Murcia, Salamanca, Valencia
- Age
- 18 years and over
- People
- 2,787 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-516654-22-00 - No phaseTaking peopleExercise to Fight Obesity
- Where
- Valencia
- Age
- 18 years to 65 years
- People
- 72
- Run by
- Instituto de Investigacion Sanitaria La Fe
See details and how to joinNCT06934681 - Phase 3Taking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- A Coruna, Barcelona, Castilleja De La Cuesta, Madrid, Pamplona, Santander, Sevilla, Valencia
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - Phase 3Taking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- A Coruña, Badalona, Barcelona, Ferrol, Madrid, Málaga, Pozuelo de Alarcón, Sevilla
- Age
- 18 years and over
- People
- 1,600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - Phase 3Taking peopleA Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Where
- A Coruna, Madrid, Pozuelo de Alarcón, Sevilla
- Age
- 18 years and over
- People
- 954 worldwide
- Run by
- Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00 - Phase 3Taking peopleA Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Where
- A coruña, Alcobendas, Barcelona, Centelles, Chiclana De La Frontera, Granada, Madrid, Sevilla, Valencia
- Age
- 18 years and over
- People
- 2,001 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07794579 · EU 2026-526175-35-00 - Phase 3Not yet taking people in SpainA Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
- Where
- Badajoz, Barcelona, León, Madrid, Santander, Santiago de Compostela
- Age
- 18 years and over
- People
- 1,408 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07919405 - Phase 3Taking peopleA Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)
- Where
- A Coruña, Barcelona, Córdoba, Sabadell, Salamanca, Santiago de Compostela, Sevilla
- Age
- 18 years and over
- People
- 656 worldwide
- Run by
- Pfizer
See details and how to joinNCT07919678 · EU 2026-526328-34-00 - Phase 3Taking peopleA Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Where
- Barcelona, Madrid, Málaga, Sabadell, Seville, Vitoria-Gasteiz
- Age
- 6 years to 17 years
- People
- 125 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06672549 - Phase 3Taking peopleMirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Where
- Barcelona, Ferrol, Gijón, Madrid, Oviedo, Pamplona, Seville, Valencia
- Age
- 18 years to 70 years
- People
- 350 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00 - Phase 3Taking peopleMirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Where
- Barcelona, Ferrol, Gijón, Madrid, Oviedo, Pamplona, Seville, Valencia
- Age
- 18 years to 70 years
- People
- 290 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00 - Phase 3Taking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Where
- Alzira, Barcelona, Castilleja De La Cuesta, Madrid, Málaga, Sevilla, Centro Médico Compostela
- Age
- 18 years and over
- People
- 1,035 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00 - Phase 3Taking peopleA Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Where
- Guadalajara, Lleida, Logroño, Madrid, Málaga, Seville
- Age
- 18 years and over
- People
- 800 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07369011 · EU 2025-523769-11-00 - Phase 3Taking peopleA Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Where
- A Coruna, Almería, Barcelona, Castilleja De La Cuesta, Ferrol, Palma, Pozuelo de Alarcón, Santander, Sevilla
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00 - Phase 3Taking peopleEfficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
- Where
- Barcelona, Madrid, Málaga, Sabadell, Seville, Vitoria-Gasteiz
- Age
- 6 years to 11 years
- People
- 150 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07817875 · EU 2025-522020-27-00 - Phase 3Taking peopleA Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- A Coruña, Alzira, Barcelona, Ferrol, Granada, Málaga, Seville
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00 - Phase 3Not yet taking people in SpainA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- A Coruña, Alzira, Castilleja De La Cuesta, Ferrol, Granada, Lugo, Madrid, Majadahonda, Palma, Pozuelo de Alarcón, Santander, Sevilla, Valencia
- Age
- 45 years to 64 years
- People
- 3,000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - Phase 3Taking peopleMaridebart Cafraglutide versus Placebo in Adult Participants with Obstructive Sleep Apnea not on Positive Airway Pressure Therapy (MARITIME-OSA-2)
- Where
- A Coruna, Barcelona, Castilleja De La Cuesta, Madrid, Pozuelo de Alarcón
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Amgen Inc.
See details and how to join2025-522699-94-00 - Phase 3Not yet taking people in SpainELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
- Where
- El Palmar, Sanlúcar de Barrameda, Valencia
- Age
- 18 years and over
- People
- 600 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07850063 · EU 2026-527091-88-00 - Phase 3Taking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- A Coruña, Badalona, Barcelona, Córdoba, Denia, El Palmar, Las Palmas de Gran Canaria, L'Hospitalet de Llobregat, Lleida, Madrid, Majadahonda, Málaga, Salamanca, Valencia
- Age
- 18 years to 99 years
- People
- 5,056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - Phase 3Taking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Where
- A Coruña, Alzira (Valencia), Barcelona, Castilleja de La Cuesta, Sevilla, Ferrol (A Coruña), Lleida, Málaga, Oviedo, Segovia, Seville
- Age
- 18 years and over
- People
- 1,500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784270 - Phase 3Not yet taking people in SpainEfficacy And Safety of Olatorepatide in Adults With Overweight or Obesity Without Diabetes
- Where
- Badajoz, Barcelona, León, Málaga, Sanlúcar de Barrameda, Sevilla, Villamartín
- Age
- 18 years and over
- People
- 3,000 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07896265 · EU 2025-524861-26-00 - Phase 3Taking peopleA Study Evaluating Mibavademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in Children, Adolescents and Adults
- Where
- Esplugues de Llobregat
- Age
- 2 years and over
- People
- 4 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07220772 · EU 2024-518674-14-00 - No phaseEnrolling by invitationEFFECT OF A ONLINE NUTRITION EDUCATION PROGRAM IN PRESCHOOLER'S FAMILIES ON THEIR ADHERENCE TO THE MEDITERRANEAN DIET
- Where
- Pamplona
- Age
- 18 months to 36 months
- People
- 160
- Run by
- Fundacion Miguel Servet
See details and how to joinNCT06828367 - No phaseTaking peopleImpact of a Perioperative Physical Exercise and Respiratory Physiotherapy Program on the Patient Undergoing Bariatric Surgery
- Where
- Vigo
- Age
- 18 years to 69 years
- People
- 132
- Run by
- Fundacin Biomedica Galicia Sur
See details and how to joinNCT06987903